Skip to content

Pralmorelin

Drug profile

Also known as: GHRP, GHRP-2, KP-102, KP-102D, pralmorelin dihydrochloride, pralmorelin HCl, pralmorelin hydrochloride

PMDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Pralmorelin is a drug catalogued in DrugCentral. It was first approved by the PMDA in 2004. DrugCentral lists 2 molecular targets, including Ghsr and GHSR. Recorded indications include Growth hormone releasing hormone test.

  • Molecular targets: Ghsr and GHSR (2 listed in DrugCentral).
  • Indications: Growth hormone releasing hormone test.
  • Molecular formula: C45H55N9O6; molecular weight 817.99 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Growth hormone releasing hormone test

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Growth hormone secretagogue receptor type 1GhsragonistKi 9.30
Growth hormone secretagogue receptor type 1GHSRagonist—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2004-10-22PMDA——

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Pralmorelin is on its molecule page.

Molecular formulaC45H55N9O6
Molecular weight817.99 g/mol
CAS number158861-67-7
InChIKeyHRNLPPBUBKMZMT-RDRUQFPZSA-N
PubChem CID6918245
C[C@@H](N)C(=O)N[C@H](CC1=CC=C2C=CC=CC2=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(N)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Pralmorelin used for?

DrugCentral lists the following indications for Pralmorelin: Growth hormone releasing hormone test.

How does Pralmorelin work?

Its molecular targets in DrugCentral include Ghsr (agonist) and GHSR (agonist).

When was Pralmorelin first approved?

Pralmorelin was first approved by the PMDA in 2004.

What is the chemical formula of Pralmorelin?

Pralmorelin has the molecular formula C45H55N9O6 and a molecular weight of 817.99 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2004-10-22
AgencyPMDA
Targets2
Indications1
FormulaC45H55N9O6
DrugCentral ID2232
Interactive profile